Wall Benjamin T
Decreased Appetite: Some individuals may experience a decrease in appetite while taking GLP-1 medications, which can be both a desired effect (supporting weight loss) and a potential side effect (leading to inadequate calorie intake)
Common side effects may include nausea, vomiting, diarrhea, abdominal pain, constipation, headache, dizziness, fatigue, or mild injection site reactions
RETA reduced blood glucose from ~ 190 mg/dL to approximately 80 mg/dL after 1 week, which steadily rose after 2 weeks of treatment over the remainder of the study to ~130 mg/dL while Veh controls maintained blood glucose ~ 180 mg/dL from baseline to endpoint (Fig
These are short-chain amino-acid sequences, with GHK-Cu being a copper-binding tripeptide, supplied together for controlled analytical and in-vitro experimentation